Abstract

BackgroundNorovirus (NoV), a member of the Caliciviridae, is now recognized as the leading cause of acute gastroenteritis (AGE) worldwide. Globally, the GII.4 Sydney_2012 variant has predominated in NoV-related AGE since 2012, although the novel variant GII.17 has also been reported as responsible for gastroenteritis outbreaks in East Asia since 2014. This study aimed to disclose the recent genotype patterns of NoV genogroup II (GII) presenting in AGE patients in Pudong New Area of Shanghai through a laboratory-based syndromic surveillance system. The study further aimed to delineate the predominant strains circulating in the population.MethodsPudong New Area is located in eastern Shanghai and covers 20.89% of the Shanghai population. The laboratory-based syndromic surveillance system is composed of 12 sentinel hospitals among the 68 general hospitals in this area. AGE patients who sought medical care were sampled following an AGE surveillance protocol. Stool samples were collected from participating patients, and a standardized questionnaire was given to each patient by trained nurses to gain information on the disease profiles and demographics of the patients. Real-time reverse transcription polymerase chain reaction (qRT-PCR) was used to screen the GI nd GII NoV and RT-PCR was used to amplify NoV GII partial capsid protein open reading frame 2 (ORF2). NoV Genotyping Tool (version 1.0, RIVM, MA Bilthoven, Netherlands) was used for genotyping, and a phylogenetic analysis was conducted by MEGA 7.0.ResultsDuring 2014–2016, among the 2069 virus-infected AGE cases, 65.88% were caused by NoV. NoV-AGE occurred most frequently in the periods from October to March. The patients with more severe diarrheal symptoms and vomiting were more likely to be infected by NoV. The main genotypes were GII.17 (44.69%) and GII.4 (39.26%), which dominated the NoV-AGE epidemics jointly or in turn, whereas a slight increase in GII.2 was observed beginning in May 2016. The GII.17 strains tended to cluster more with the Hu/JP/2014/GII.P17_GII.17/Kawasaki323 variants, representing novel prevalent strains. Among the GII.4 strains, the GII.4 Sydney_2012 variant was still the predominant strain.ConclusionsNoV GII has become the main cause of virus-infected AGE in Pudong New Area, Shanghai. The predominant genotypes of NoV GII were GII.17 and GII.4. Comprehensive laboratory-based surveillance is important for clinical diagnosis and treatment. Identification of emerging new genotypes is also crucial for the prevention and control of NoV-infected AGE.

Highlights

  • Norovirus (NoV), a member of the Caliciviridae, is recognized as the leading cause of acute gastroenteritis (AGE) worldwide

  • This study aimed to study the molecular epidemiology of genogroup II (GII) NoV presenting in AGE patients in Pudong New Area of Shanghai through a laboratorybased syndromic surveillance system and, to delineate the dominant strains circulating in the population in recent years

  • Composition of GII NoV infection in AGE patients A total of 866 NoV GII strains among 1363 GII NoVAGE were further genotyped by sequencing the partial nucleotide sequence of open reading frame 2 (ORF2)

Read more

Summary

Introduction

Norovirus (NoV), a member of the Caliciviridae, is recognized as the leading cause of acute gastroenteritis (AGE) worldwide. Sydney_2012 variant has predominated in NoV-related AGE since 2012, the novel variant GII. has been reported as responsible for gastroenteritis outbreaks in East Asia since 2014. This study aimed to disclose the recent genotype patterns of NoV genogroup II (GII) presenting in AGE patients in Pudong New Area of Shanghai through a laboratory-based syndromic surveillance system. To support early detection of and response to AGE epidemics, a laboratory-based syndromic surveillance system was established in 2010 in Pudong New Area of Shanghai. Laboratory capacity, and geographic location, 12 of the 68 general hospitals in this area were selected as sentinel hospitals for AGE syndromic surveillance. The surveillance system includes three tertiary general hospitals, seven secondary general hospitals and three community health care centers covering about 71.2% AGE patients per year

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call